Norimasa Kaneda

611 total citations
17 papers, 543 citations indexed

About

Norimasa Kaneda is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Norimasa Kaneda has authored 17 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in Norimasa Kaneda's work include Cancer therapeutics and mechanisms (11 papers), Lung Cancer Research Studies (7 papers) and Neutropenia and Cancer Infections (4 papers). Norimasa Kaneda is often cited by papers focused on Cancer therapeutics and mechanisms (11 papers), Lung Cancer Research Studies (7 papers) and Neutropenia and Cancer Infections (4 papers). Norimasa Kaneda collaborates with scholars based in Japan and Italy. Norimasa Kaneda's co-authors include Teruo Yokokura, Akinobu Kurita, Shoichi Kado, Masaharu Onoue, Shusuke Hashimoto, Tatsuya Tsuji, Daisuke Tsuru, Tsuneo Matsumoto, Ikuo Kato and Yuusuke Uchida and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Pharmacology and BMC Cancer.

In The Last Decade

Norimasa Kaneda

17 papers receiving 516 citations

Peers

Norimasa Kaneda

MB

ONCOL

PHARM

PRM

BIOMA

Viral Vyas United States

Zujun Que China

Yu-Shan Wu Taiwan

Peter Tobin Australia

Kazumi Sano Japan

Bhavani S. Shankar India

Jing Ding China

Samir Mehndiratta Taiwan

Reyaz ur Rasool India

Xiaonan Xi China

Viral Vyas United States

Norimasa Kaneda

271 ×0.7

MB

188 ×0.7

ONCOL

52 ×0.4

PHARM

23 ×0.3

PRM

28 ×0.6

BIOMA

Citations per year, relative to Norimasa Kaneda Norimasa Kaneda (= 1×) peers Viral Vyas

Countries citing papers authored by Norimasa Kaneda

Since Specialization

Citations

This map shows the geographic impact of Norimasa Kaneda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norimasa Kaneda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norimasa Kaneda more than expected).

Fields of papers citing papers by Norimasa Kaneda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norimasa Kaneda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norimasa Kaneda. The network helps show where Norimasa Kaneda may publish in the future.

Co-authorship network of co-authors of Norimasa Kaneda

This figure shows the co-authorship network connecting the top 25 collaborators of Norimasa Kaneda. A scholar is included among the top collaborators of Norimasa Kaneda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norimasa Kaneda. Norimasa Kaneda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Konishi, Hiroaki, Akimitsu Takagi, Akinobu Kurita, Norimasa Kaneda, & Takeshi Matsuzaki. (2012). PEGylated liposome IHL-305 markedly improved the survival of ovarian cancer peritoneal metastasis in mouse. BMC Cancer. 12(1). 462–462. 7 indexed citations

2.

Kurita, Akinobu, Shoichi Kado, Tsuneo Matsumoto, et al.. (2010). Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of β-glucuronidase activity in intestinal lumen. Cancer Chemotherapy and Pharmacology. 67(1). 201–213. 58 indexed citations

3.

Onoue, Masaharu, Akinobu Kurita, Shoichi Kado, et al.. (2007). Involvement of UDP-glucuronosyltransferase activity in irinotecan-induced delayed-onset diarrhea in rats. Cancer Chemotherapy and Pharmacology. 61(4). 595–605. 12 indexed citations

4.

Guiotto, Andrea, Norimasa Kaneda, Akinobu Kurita, et al.. (2004). Efficient and chemoselective N-acylation of 10-amino-7-ethyl camptothecin with poly(ethylene glycol). Bioorganic & Medicinal Chemistry Letters. 14(7). 1803–1805. 7 indexed citations

5.

Guiotto, Andrea, Norimasa Kaneda, Akinobu Kurita, et al.. (2004). Synthesis, Characterization, and Preliminary in Vivo Tests of New Poly(ethylene glycol) Conjugates of the Antitumor Agent 10-Amino-7-ethylcamptothecin. Journal of Medicinal Chemistry. 47(14). 3705–3705. 1 indexed citations

6.

Guiotto, Andrea, Norimasa Kaneda, Akinobu Kurita, et al.. (2004). Synthesis, Characterization, and Preliminary in Vivo Tests of New Poly(ethylene glycol) Conjugates of the Antitumor Agent 10-Amino-7-ethylcamptothecin. Journal of Medicinal Chemistry. 47(5). 1280–1289. 17 indexed citations

7.

Kurita, Akinobu, Shoichi Kado, Norimasa Kaneda, et al.. (2003). Alleviation of side effects induced by irinotecan hydrochloride (CPT-11) in rats by intravenous infusion. Cancer Chemotherapy and Pharmacology. 52(5). 349–360. 25 indexed citations

8.

Kurita, Akinobu, Shoichi Kado, Norimasa Kaneda, et al.. (2000). Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats. Cancer Chemotherapy and Pharmacology. 46(3). 211–220. 82 indexed citations

9.

Kurita, Akinobu & Norimasa Kaneda. (1999). High-performance liquid chromatographic method for the simultaneous determination of the camptothecin derivative irinotecan hydrochloride, CPT-11, and its metabolites SN-38 and SN-38 glucuronide in rat plasma with a fully automated on-line solid-phase extraction system, PROSPEKT. Journal of Chromatography B Biomedical Sciences and Applications. 724(2). 335–344. 60 indexed citations

10.

Kaneda, Norimasa, et al.. (1997). Plasma Pharmacokinetics of 7-Ethyl-10-hydroxycamptothecin (SN-38) after Intravenous Administration of SN-38 and Irinotecan (CPT-11) to Rats.. Biological and Pharmaceutical Bulletin. 20(9). 992–996. 10 indexed citations

11.

Kaneda, Norimasa, et al.. (1997). Simultaneous Determination of the Lactone and Carboxylate Forms of 7-Ethyl-10 hydroxycamptothecin (SN-38), the Active Metabolite of Irinotecan (CPT-11), in Rat Plasma by High Performance Liquid Chromatography.. Biological and Pharmaceutical Bulletin. 20(7). 815–819. 22 indexed citations

12.

Yamazaki, Ryuta, Shinichi Kawai, Takeshi Matsuzaki, et al.. (1997). Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors. European Journal of Pharmacology. 329(2-3). 181–187. 63 indexed citations

13.

Komuro, Hiroaki, Yoshiaki Tsuchida, Kinji Yokomori, et al.. (1994). Effects of CPT‐11 (a unique DNA topoisomerase I inhibitor) on a highly malignant xeno‐transplanted neuroblastoma. Medical and Pediatric Oncology. 23(6). 487–492. 36 indexed citations

14.

Tsuji, Tatsuya, et al.. (1991). CPT-11 Converting Enzyme from Rat Serum: Purification and Some Properties.. Journal of Pharmacobio-Dynamics. 14(6). 341–349. 126 indexed citations

15.

Shibata, Kozo, Tadao Kamikawa, Norimasa Kaneda, & Makoto Taniguchi. (1978). A NEW METABOLITE, ASPERMUTARUBROL, FROM ASPERGILLUS SYDOWI. Chemistry Letters. 7(7). 797–798. 7 indexed citations

16.

Taniguchi, Makoto, Norimasa Kaneda, Kozo Shibata, & Tadao Kamikawa. (1978). Isolation and Biological Activity of Aspermutarubrol, a Self-growth- inhibitor from Aspergillus sydowi. Agricultural and Biological Chemistry. 42(8). 1629–1630. 2 indexed citations

17.

Taniguchi, Makoto, Norimasa Kaneda, Kozo Shibata, & Tadao Kamikawa. (1978). Isolation and biological activity of aspermutarubrol, a self-growthinhibitor from Aspergillus sydowi.. Agricultural and Biological Chemistry. 42(8). 1629–1630. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact